What is the Role of Triglyceride-glucose Index as a Predictive Marker for Insulin Resistance in Pre Diabetic Chronic Kidney Disease Patients?

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

The aim of this study is to evaluate the role of the triglyceride-glucose (TyG) index as a predictive marker for insulin resistance in pre-diabetic patients with chronic kidney disease (CKD), and to investigate its potential utility as a simple, non-invasive alternative to traditional insulin resistance assessment methods.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged ≥18 years

Disqualifiers

Known type 1 or type 2 diabetes mellitus

Trial population

Adults aged ≥18 years with medical history free from renal dysfunction or with renal dysfunction (CKD stages 2\_5 based on KDIGO guidelines)

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • Triglyceride-glucose index

    Diagnostic test

    Triglyceride-glucose index calculation according to TyG index=In\[Triglycerides(mg/dl)×Fasting Glucose(mg/dl)/2\]

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Diagnostic performance of TyG index

Diagnostic performance of TyG index in predicting prediabetics and diabetic patients.

Time frame
2 years

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: